Friday, May 3, 2024
ADVT 
International

US buys more monkeypox vaccine as global case count grows

Darpan News Desk The Canadian Press, 10 Jun, 2022 01:23 PM
  • US buys more monkeypox vaccine as global case count grows

NEW YORK (AP) — The U.S. government is buying more monkeypox vaccine as a surprising international outbreak continues to grow, health officials said Friday.

As of Friday, the U.S. had identified 45 cases in 15 states and the District of Columbia. More than 1,300 cases have been found in about 30 other countries outside the areas of Africa where the virus is endemic.

Officials say the risk to the American public is low, but they are taking steps to assure people that medical measures are in place to deal with the growing problem .

A two-dose vaccine, Jynneos, is approved for monkeypox in the U.S.

The U.S. government has 72,000 Jynneos doses, and will get 300,000 more doses from its manufacturer, Bavarian Nordic, over the next several weeks, said Dawn O’Connell, who oversees the government’s stockpile of emergency vaccines and treatments.

On Friday, the government announced it had ordered 500,000 more Jynneos doses from Bavarian Nordic to be delivered late this year. The company also is holding other doses owned by the U.S. government, she said.

“We have the vaccines and treatments we need to respond,” said O’Connell, of the U.S. Department of Health and Human Services.

Monkeypox is endemic in parts of Africa , where people have been infected through bites from rodents or small animals. It does not usually spread easily among people.

Last month, cases began emerging in Europe and the United States. Many — but not all — of those who contracted the virus had traveled internationally. Most were men who have sex with men, but health officials stress that anyone can get monkeypox.

The Centers for Disease Control and Prevention said Friday that every U.S. case they had looked at involved very close contact.

Officials have alerted doctors to watch for monkeypox cases and offered vaccinations to people in contact with those who were infected.

So far, over 1,400 vaccine courses and over 110 treatment courses have been sent to affected state and local jurisdictions, officials said.

MORE International ARTICLES

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

China permits Indian students to return on 'need-assessed' basis

China permits Indian students to return on 'need-assessed' basis
According to the Embassy, following the meeting of External Affairs Minister S. Jaishankar with his Chinese counterpart Wang Yi on March 25, the Chinese side has expressed its willingness to consider facilitating the return of Indian students to China on a need-assessed basis.

China permits Indian students to return on 'need-assessed' basis